Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Altemus

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Biological Psychiatry|April 15, 1999
Normal CSF oxytocin and NPY levels in OCDM Altemus, K R Jacobson, M Debellis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Ectopic Cushing's syndrome caused by an esthesioneuroblastomaJuan Yu, Christian A Koch, Athos Patsalides, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1992
Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjectsM A Demitrack, K T Kalogeras, M Altemus, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleusM A Smith, S Makino, M Altemus, et al.
Psychopharmacology Bulletin|January 1, 1995
Algorithm for the treatment of obsessive-compulsive disorder (OCD)J W Jefferson, M Altemus, M A Jenike, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorderM Karayiorgou, M Altemus, B L Galke, et al.
Archives of General Psychiatry|January 1, 1992
Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorderM Altemus, T Pigott, K T Kalogeras, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycleM Altemus, L Redwine, Y M Leong, et al.
Psychopharmacology|January 15, 1999
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patientsB D Greenberg, J Benjamin, J D Martin, et al.
The American Journal of Psychiatry|August 1, 1991
Decrease in resting metabolic rate during abstinence from bulimic behaviorM Altemus, M M Hetherington, M Flood, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Biological Psychiatry|April 15, 1999
Normal CSF oxytocin and NPY levels in OCDM Altemus, K R Jacobson, M Debellis, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Ectopic Cushing's syndrome caused by an esthesioneuroblastomaJuan Yu, Christian A Koch, Athos Patsalides, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1992
Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjectsM A Demitrack, K T Kalogeras, M Altemus, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus coeruleusM A Smith, S Makino, M Altemus, et al.
Psychopharmacology Bulletin|January 1, 1995
Algorithm for the treatment of obsessive-compulsive disorder (OCD)J W Jefferson, M Altemus, M A Jenike, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 29, 1997
Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorderM Karayiorgou, M Altemus, B L Galke, et al.
Archives of General Psychiatry|January 1, 1992
Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorderM Altemus, T Pigott, K T Kalogeras, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 1, 1997
Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycleM Altemus, L Redwine, Y M Leong, et al.
Psychopharmacology|January 15, 1999
Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patientsB D Greenberg, J Benjamin, J D Martin, et al.
The American Journal of Psychiatry|August 1, 1991
Decrease in resting metabolic rate during abstinence from bulimic behaviorM Altemus, M M Hetherington, M Flood, et al.
Pageof 7